CombinatoRx (www.combinatorx.com) is tapping Tripos Discovery Research (TDR; www.triposdiscoveryresearch.com) technology through a service agreement. CombinatoRx has identified synergistic activity of compounds with its combination high-throughput screening technology, cHTS™. Under the service contract, TDR will optimize these candidates and partner ADME services.
